 | • レポートコード：B-GIR09D4193 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、パーソナライズ癌医学の世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、個別化癌ワクチン、その他等、用途別セグメントは、乳癌、肺癌、慢性骨髄性白血病、腸癌、その他癌等に区分しました。パーソナライズ癌医学の世界市場概観、企業動向、企業別パーソナライズ癌医学シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・パーソナライズ癌医学の市場概観 ・パーソナライズ癌医学の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・パーソナライズ癌医学の企業別販売動向、市場シェア、市場集中度、競争動向 ・パーソナライズ癌医学の世界市場規模 ・パーソナライズ癌医学の北米市場分析（アメリカ、カナダ、メキシコ等） ・パーソナライズ癌医学のアメリカ市場規模推移 ・パーソナライズ癌医学のカナダ市場規模推移 ・パーソナライズ癌医学のメキシコ市場規模推移 ・パーソナライズ癌医学のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・パーソナライズ癌医学のドイツ市場規模推移 ・パーソナライズ癌医学のイギリス市場規模推移 ・パーソナライズ癌医学のロシア市場規模推移 ・パーソナライズ癌医学のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・パーソナライズ癌医学の日本市場規模推移 ・パーソナライズ癌医学の中国市場規模推移 ・パーソナライズ癌医学の韓国市場規模推移 ・パーソナライズ癌医学のインド市場規模推移 ・パーソナライズ癌医学の東南アジア市場規模推移 ・パーソナライズ癌医学の南米市場分析（ブラジル、アルゼンチン等） ・パーソナライズ癌医学の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・パーソナライズ癌医学の種類別分析/販売量、売上、市場シェア（モノクローナル抗体、個別化癌ワクチン、その他） ・パーソナライズ癌医学の用途別分析/市場規模（乳癌、肺癌、慢性骨髄性白血病、腸癌、その他癌） ・パーソナライズ癌医学の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・パーソナライズ癌医学の販売チャネル・代理店・貿易業者・ディーラー分析 |
Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.
Scope of the Report:
The global Personalized Cancer Medicine market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Personalized Cancer Medicine.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Personalized Cancer Medicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Personalized Cancer Medicine market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Personalized Cancer Vaccines
Other
Market Segment by Applications, can be divided into
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer
Table of Contents
1 Personalized Cancer Medicine Market Overview
1.1 Product Overview and Scope of Personalized Cancer Medicine
1.2 Classification of Personalized Cancer Medicine by Types
1.2.1 Global Personalized Cancer Medicine Revenue Comparison by Types (2019-2024)
1.2.2 Global Personalized Cancer Medicine Revenue Market Share by Types in 2018
1.2.3 Monoclonal Antibodies
1.2.4 Personalized Cancer Vaccines
1.2.5 Other
1.3 Global Personalized Cancer Medicine Market by Application
1.3.1 Global Personalized Cancer Medicine Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Chronic Myeloid Leukaemia
1.3.5 Bowel Cancer
1.3.6 Other Cancer
1.4 Global Personalized Cancer Medicine Market by Regions
1.4.1 Global Personalized Cancer Medicine Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.5 Global Market Size of Personalized Cancer Medicine (2014-2024)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Personalized Cancer Medicine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 Personalized Cancer Medicine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Personalized Cancer Medicine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Personalized Cancer Medicine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.5 Celgene
2.5.1 Business Overview
2.5.2 Personalized Cancer Medicine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celgene Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Personalized Cancer Medicine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.7 Roche
2.7.1 Business Overview
2.7.2 Personalized Cancer Medicine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.8 Astellas
2.8.1 Business Overview
2.8.2 Personalized Cancer Medicine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Astellas Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.9 Astrazeneca
2.9.1 Business Overview
2.9.2 Personalized Cancer Medicine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Astrazeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Personalized Cancer Medicine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.11 Agilent
2.11.1 Business Overview
2.11.2 Personalized Cancer Medicine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Agilent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.12 Takeda
2.12.1 Business Overview
2.12.2 Personalized Cancer Medicine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
3 Global Personalized Cancer Medicine Market Competition, by Players
3.1 Global Personalized Cancer Medicine Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Personalized Cancer Medicine Players Market Share
3.2.2 Top 10 Personalized Cancer Medicine Players Market Share
3.3 Market Competition Trend
4 Global Personalized Cancer Medicine Market Size by Regions
4.1 Global Personalized Cancer Medicine Revenue and Market Share by Regions
4.2 North America Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
4.3 Europe Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
4.5 South America Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
5 North America Personalized Cancer Medicine Revenue by Countries
5.1 North America Personalized Cancer Medicine Revenue by Countries (2014-2019)
5.2 USA Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
5.3 Canada Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
5.4 Mexico Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6 Europe Personalized Cancer Medicine Revenue by Countries
6.1 Europe Personalized Cancer Medicine Revenue by Countries (2014-2019)
6.2 Germany Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6.3 UK Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6.4 France Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6.5 Russia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6.6 Italy Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Personalized Cancer Medicine Revenue by Countries
7.1 Asia-Pacific Personalized Cancer Medicine Revenue by Countries (2014-2019)
7.2 China Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7.3 Japan Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7.4 Korea Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7.5 India Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
8 South America Personalized Cancer Medicine Revenue by Countries
8.1 South America Personalized Cancer Medicine Revenue by Countries (2014-2019)
8.2 Brazil Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
8.3 Argentina Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
8.4 Colombia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Personalized Cancer Medicine by Countries
9.1 Middle East and Africa Personalized Cancer Medicine Revenue by Countries (2014-2019)
9.2 Saudi Arabia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9.3 UAE Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9.4 Egypt Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9.5 Nigeria Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9.6 South Africa Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
10 Global Personalized Cancer Medicine Market Segment by Type
10.1 Global Personalized Cancer Medicine Revenue and Market Share by Type (2014-2019)
10.2 Global Personalized Cancer Medicine Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
10.4 Personalized Cancer Vaccines Revenue Growth Rate (2014-2024)
10.5 Other Revenue Growth Rate (2014-2024)
11 Global Personalized Cancer Medicine Market Segment by Application
11.1 Global Personalized Cancer Medicine Revenue Market Share by Application (2014-2019)
11.2 Personalized Cancer Medicine Market Forecast by Application (2019-2024)
11.3 Breast Cancer Revenue Growth (2014-2019)
11.4 Lung Cancer Revenue Growth (2014-2019)
11.5 Chronic Myeloid Leukaemia Revenue Growth (2014-2019)
11.6 Bowel Cancer Revenue Growth (2014-2019)
11.7 Other Cancer Revenue Growth (2014-2019)
12 Global Personalized Cancer Medicine Market Size Forecast (2019-2024)
12.1 Global Personalized Cancer Medicine Market Size Forecast (2019-2024)
12.2 Global Personalized Cancer Medicine Market Forecast by Regions (2019-2024)
12.3 North America Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
12.4 Europe Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
12.6 South America Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Personalized Cancer Medicine Picture
Table Product Specifications of Personalized Cancer Medicine
Table Global Personalized Cancer Medicine and Revenue (Million USD) Market Split by Product Type
Figure Global Personalized Cancer Medicine Revenue Market Share by Types in 2018
Figure Monoclonal Antibodies Picture
Figure Personalized Cancer Vaccines Picture
Figure Other Picture
Table Global Personalized Cancer Medicine Revenue (Million USD) by Application (2014-2024)
Figure Personalized Cancer Medicine Revenue Market Share by Applications in 2018
Figure Breast Cancer Picture
Figure Lung Cancer Picture
Figure Chronic Myeloid Leukaemia Picture
Figure Bowel Cancer Picture
Figure Other Cancer Picture
Table Global Market Personalized Cancer Medicine Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Personalized Cancer Medicine Type and Applications
Table Abbott Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Personalized Cancer Medicine Type and Applications
Table Merck Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Personalized Cancer Medicine Type and Applications
Table Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Personalized Cancer Medicine Type and Applications
Table Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Personalized Cancer Medicine Type and Applications
Table Celgene Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Personalized Cancer Medicine Type and Applications
Table Bayer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Personalized Cancer Medicine Type and Applications
Table Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Personalized Cancer Medicine Type and Applications
Table Astellas Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Astrazeneca Basic Information, Manufacturing Base and Competitors
Table Astrazeneca Personalized Cancer Medicine Type and Applications
Table Astrazeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Personalized Cancer Medicine Type and Applications
Table Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Agilent Basic Information, Manufacturing Base and Competitors
Table Agilent Personalized Cancer Medicine Type and Applications
Table Agilent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Personalized Cancer Medicine Type and Applications
Table Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Global Personalized Cancer Medicine Revenue (Million USD) by Players (2014-2019)
Table Global Personalized Cancer Medicine Revenue Share by Players (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Players in 2017
Figure Global Personalized Cancer Medicine Revenue Share by Players in 2018
Figure Global Top 5 Players Personalized Cancer Medicine Revenue Market Share in 2018
Figure Global Top 10 Players Personalized Cancer Medicine Revenue Market Share in 2018
Figure Global Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Personalized Cancer Medicine Revenue (Million USD) by Regions (2014-2019)
Table Global Personalized Cancer Medicine Revenue Market Share by Regions (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Market Share by Regions (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Market Share by Regions in 2018
Figure North America Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Europe Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure South America Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table North America Personalized Cancer Medicine Revenue by Countries (2014-2019)
Table North America Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure North America Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure North America Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure USA Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Canada Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Mexico Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table Europe Personalized Cancer Medicine Revenue (Million USD) by Countries (2014-2019)
Figure Europe Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure Europe Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure Germany Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure UK Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure France Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Russia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Italy Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Personalized Cancer Medicine Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure China Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Japan Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Korea Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure India Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table South America Personalized Cancer Medicine Revenue by Countries (2014-2019)
Table South America Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure South America Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure South America Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure Brazil Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Argentina Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Colombia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Personalized Cancer Medicine Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure UAE Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Egypt Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Nigeria Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure South Africa Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table Global Personalized Cancer Medicine Revenue (Million USD) by Type (2014-2019)
Table Global Personalized Cancer Medicine Revenue Share by Type (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Type (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Type in 2019
Table Global Personalized Cancer Medicine Revenue Forecast by Type (2019-2024)
Figure Global Personalized Cancer Medicine Market Share Forecast by Type (2019-2024)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)
Figure Global Personalized Cancer Vaccines Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Personalized Cancer Medicine Revenue by Application (2014-2019)
Table Global Personalized Cancer Medicine Revenue Share by Application (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Application (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Application in 2019
Table Global Personalized Cancer Medicine Revenue Forecast by Application (2019-2024)
Figure Global Personalized Cancer Medicine Market Share Forecast by Application (2019-2024)
Figure Global Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Lung Cancer Revenue Growth Rate (2014-2019)
Figure Global Chronic Myeloid Leukaemia Revenue Growth Rate (2014-2019)
Figure Global Bowel Cancer Revenue Growth Rate (2014-2019)
Figure Global Other Cancer Revenue Growth Rate (2014-2019)
Figure Global Personalized Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Personalized Cancer Medicine Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Personalized Cancer Medicine Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
Figure Europe Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
Figure South America Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
パーソナライズ型パッケージ市場：世界及び中国市場分析・予測（～2024年） Personalized Packaging Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Personalized Packaging industry with a focus on the Chinese market. The report provides key statistics on the market status of the Personalized Packaging m…- 世界の新がん診断市場予測（～2024年） Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation. Scope of the Report: The global Emerging Cancer Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between …
- 世界のがん治療用遺伝子治療市場予測（～2024年） Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…
- 世界の虫垂癌治療市場予測（～2024年） The appendix is a tube-like structure, which is three to six inches long and is attached to the colon. It is situated in the lower right part of the abdomen. Appendix cancer are rare cancers of the vermiform appendix. Scope of the Report: The global Appendix Cancer Treatment market is valued at xx m…
- 世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…